Literature DB >> 27206949

Superiority of lipoprotein particle number to detect associations with arterial thickness and stiffness in obese youth with and without prediabetes.

Amy S Shah1, W Sean Davidson2, Zhiqian Gao3, Lawrence M Dolan4, Thomas R Kimball3, Elaine M Urbina3.   

Abstract

BACKGROUND: The nuclear magnetic resonance (NMR) lipoprotein profile provides additional cardiovascular risk information beyond traditional lipids in high-risk adults. Similar studies have not been conducted in youth.
OBJECTIVE: To evaluate the relationship between the NMR profile and preclinical vascular measures in youth.
METHODS: We studied 96 obese youth with prediabetes (mean age = 18.1 ± 3.6 years, 63% female, 78% African American) and 118 obese normoglycemic controls (mean age = 18.0 ± 3.1 years, 75% female, 62% African American) cross sectionally. Traditional lipids (triglycerides, total, high-density lipoprotein [HDL], and low-density lipoprotein [LDL] cholesterol), NMR particle size (particle concentration [P] and size) and vascular thickness (carotid IMT) and stiffness (pulse wave velocity [PWV]) were measured. Independent associations between lipoproteins with carotid IMT and PWV after adjustment for group, age, race, sex, BMI z score, blood pressure, HOMA-IR, and A1c were studied.
RESULTS: NMR analysis revealed youth with prediabetes exhibited a more atherogenic profile with higher levels of small LDL-P and HDL-P and lower levels of intermediate and large HDL-P (P < .03). In addition, lower intermediate HDL-P was associated with a higher carotid IMT, whereas higher small HDL-P was associated with a higher PWV (P < .01). Traditional lipids were not significantly different between groups and were not associated with either vascular outcome.
CONCLUSIONS: NMR lipoprotein subclasses have improved sensitivity compared to traditional lipids to detect lipoprotein abnormalities in normoglycemic and prediabetic obese youth and are independently associated with preclinical vascular thickness and stiffness. NMR lipids may enhance cardiovascular risk assessment in youth.
Copyright © 2016 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lipids; Lipoproteins; Obesity; Pediatrics; Prediabetes; Vasculature

Mesh:

Substances:

Year:  2016        PMID: 27206949      PMCID: PMC4876956          DOI: 10.1016/j.jacl.2016.01.007

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  44 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  H N Ginsberg
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

3.  Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus.

Authors:  Elaine M Urbina; Thomas R Kimball; Philip R Khoury; Stephen R Daniels; Lawrence M Dolan
Journal:  J Hypertens       Date:  2010-08       Impact factor: 4.844

Review 4.  Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

Authors:  Elias J Jeyarajah; William C Cromwell; James D Otvos
Journal:  Clin Lab Med       Date:  2006-12       Impact factor: 1.935

5.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

6.  Prediabetes: the effects on arterial thickness and stiffness in obese youth.

Authors:  Amy S Shah; Zhiqian Gao; Elaine M Urbina; Thomas R Kimball; Lawrence M Dolan
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

7.  Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998.

Authors:  Lloyd E Chambless; Aaron R Folsom; Vicki Davis; Richey Sharrett; Gerardo Heiss; Paul Sorlie; Moyses Szklo; George Howard; Gregory W Evans
Journal:  Am J Epidemiol       Date:  2002-01-01       Impact factor: 4.897

8.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

9.  LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.

Authors:  William C Cromwell; James D Otvos; Michelle J Keyes; Michael J Pencina; Lisa Sullivan; Ramachandran S Vasan; Peter W F Wilson; Ralph B D'Agostino
Journal:  J Clin Lipidol       Date:  2007-12       Impact factor: 4.766

10.  Relation of black race between high density lipoprotein cholesterol content, high density lipoprotein particles and coronary events (from the Dallas Heart Study).

Authors:  Alvin Chandra; Ian J Neeland; Sandeep R Das; Amit Khera; Aslan T Turer; Colby R Ayers; Darren K McGuire; Anand Rohatgi
Journal:  Am J Cardiol       Date:  2015-01-15       Impact factor: 2.778

View more
  8 in total

1.  Postprandial Dyslipidemia, Hyperinsulinemia, and Impaired Gut Peptides/Bile Acids in Adolescents with Obesity.

Authors:  Victoria Higgins; Shervin Asgari; Jill K Hamilton; Anna Wolska; Alan T Remaley; Bolette Hartmann; Jens J Holst; Khosrow Adeli
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

2.  Obesity is associated with an altered HDL subspecies profile among adolescents with metabolic disease.

Authors:  W Sean Davidson; Anna Heink; Hannah Sexmith; Lawrence M Dolan; Scott M Gordon; James D Otvos; John T Melchior; Deborah A Elder; Jane Khoury; Esmond Geh; Amy S Shah
Journal:  J Lipid Res       Date:  2017-07-25       Impact factor: 5.922

3.  Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects.

Authors:  Flávia De C Cartolano; Gabriela D Dias; Maria C P de Freitas; Antônio M Figueiredo Neto; Nágila R T Damasceno
Journal:  J Diabetes Res       Date:  2017-08-22       Impact factor: 4.011

4.  Lipoprotein particles in patients with pediatric Cushing disease and possible cardiovascular risks.

Authors:  Angeliki Makri; Anita Cheung; Ninet Sinaii; Alan T Remaley; Maureen Sampson; Meg Keil; Elena Belyavskaya; Charalampos Lyssikatos; Maria De La Luz Sierra; Constantine A Stratakis; Maya Lodish
Journal:  Pediatr Res       Date:  2019-05-21       Impact factor: 3.756

5.  Cross-sectional associations between cardiorespiratory fitness and NMR-derived metabolic biomarkers in children - the PANIC study.

Authors:  Eero A Haapala; Marja H Leppänen; Maarit Lehti; Niina Lintu; Tuomo Tompuri; Anna Viitasalo; Ursula Schwab; Timo A Lakka
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

6.  Plasma Levels of Retinol Binding Protein 4 Relate to Large VLDL and Small LDL Particles in Subjects with and without Type 2 Diabetes.

Authors:  Hanna Wessel; Ali Saeed; Janette Heegsma; Margery A Connelly; Klaas Nico Faber; Robin P F Dullaart
Journal:  J Clin Med       Date:  2019-10-25       Impact factor: 4.241

7.  Postprandial dyslipidemia in insulin resistant states in adolescent populations.

Authors:  Victoria Higgins; Khosrow Adeli
Journal:  J Biomed Res       Date:  2020-01-30

8.  Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study.

Authors:  Bárbara Fernández-Cidón; Beatriz Candás-Estébanez; Miriam Gil-Serret; Núria Amigó; Emili Corbella; M Ángeles Rodríguez-Sánchez; Ariadna Padró-Miquel; Carlos Brotons; Antonio Hernández-Mijares; Pilar Calmarza; Estibaliz Jarauta; Angel J Brea; Marta Mauri; Carlos Guijarro; Àlex Vila; Pedro Valdivielso; Xavier Corbella; Xavier Pintó
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.